Transcriptome modification of white blood cells after dietary administration of curcumin and non-steroidal anti-inflammatory drug in osteoarthritic affected dogs

Veterinary Immunology and Immunopathology

Volumn 147, Issue 3-4, 2012, Pages 136-146

  Colitti, M ^a   Gaspardo, B ^a   Della Pria, A ^b   Scaini, C ^a   Stefanon, Bruno ^a  

^a UNIVERSITY OF UDINE   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

Author keywords

Curcumin; Dog; Microarray; NSAID; Osteoarthritis

Indexed keywords

BIOLOGICAL MARKER; CURCUMIN; CURCUVET; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; FIROCOXIB; I KAPPA B; INTERLEUKIN 18; INTERLEUKIN 8; MITOGEN ACTIVATED PROTEIN KINASE 14; TOLL LIKE RECEPTOR 4; TRANSCRIPTOME; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; ARTICLE; BLOOD SAMPLING; CELL COMMUNICATION; CELL MIGRATION; CELL MOTION; COMPUTER PROGRAM; CONNECTIVE TISSUE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET SUPPLEMENTATION; DOG; DOWN REGULATION; DRUG TARGETING; FEMALE; FIBRINOLYSIS; GENE EXPRESSION; GENE TARGETING; GENETIC REGULATION; GENETIC TRANSCRIPTION; IMMUNOCOMPETENT CELL; INFLAMMATION; LEUKOCYTE; MACROPHAGE; MALE; MICROARRAY ANALYSIS; NONHUMAN; OSTEOARTHRITIS; SIGNAL TRANSDUCTION; TREATMENT DURATION; UPREGULATION;

ADMINISTRATION, ORAL; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BASE SEQUENCE; CURCUMIN; DIETARY SUPPLEMENTS; DOG DISEASES; DOGS; FEMALE; GENE EXPRESSION; GENETIC MARKERS; LEUKOCYTES; MALE; OSTEOARTHRITIS; REAL-TIME POLYMERASE CHAIN REACTION; RNA; SIGNAL TRANSDUCTION; TRANSCRIPTOME;

CANIS FAMILIARIS;

EID: 84861482813     PISSN: 01652427     EISSN: 18732534     Source Type: Journal    
DOI: 10.1016/j.vetimm.2012.04.001     Document Type: Article

References (48)

1. Aggarwal B.B., Takada Y., Shishodia S., Gutierrez A.M., Oommen O.V., Ichikawa H., Baba Y., Kumar A. Nuclear transcription factor NF-κB: role in biology and medicine. Indian J. Exp. Biol. 2004, 42:341-353.
2. Aggarwal B.B., Harikumar K.B. Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases. Int. J. Biochem. Cell Biol. 2009, 41:40-59.
3. Anand P., Sung B., Kunnumakkara A.B., Rajasekharan K.N., Aggarwal B.B. Suppression of pro-inflammatory and proliferative pathways by diferuloylmethane (curcumin) and its analogues dibenzoylmethane, dibenzoylpropane, and dibenzylideneacetone: role of Michael acceptors and Michael donors. Biochem. Pharmacol. 2011, 82:1901-1909.
4. Bennet D. Joints and joint diseases. Canine Orthopedics 1990, Lea & Febiger, Philadelphia, pp. 776-778. W. Whittick (Ed.).
5. Bharti A.C., Takada Y., Aggarwal B.B. Curcumin (diferuloylmethane) inhibits receptor activator of NF-κB ligand-induced NF-κB activation in osteoclast precursors and suppresses osteoclastogenesis. J. Immunol. 2004, 172:5940-5947.
6. Bolstad B.M., Irizarry R.A., Astrand M., Speed T.P. A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 2003, 19:185-193.
7. Boraschi D., Dinarello C.A. IL-18 in autoimmunity: review. Eur. Cytokine Netw. 2006, 17:224-252.
8. Buhrmann C., Mobasheri A., Busch F., Aldinger C., Stahlmann R., Montaseri A., Shakibaei M. Curcumin modulates nuclear factor κB (NF-κB)-mediated inflammation in human tenocytes in vitro: role of the phosphatidylinositol 3-kinase/Akt pathway. J. Biol. Chem. 2011, 286:28556-28566.
9. Bustin S.A., Benes V., Garson J.A., Hellemans J., Huggett J., Kubista M., Mueller R., Nolan T., Pfaffl M.W., Shipley G.L., Vandesompele J., Wittwer C.T. The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin. Chem. 2009, 55:611-622.
10. Buttgereit F., Burmester G.R., Simon L.S. Gastrointestinal toxic side effects of nonsteroidal anti-inflammatory drugs and cyclooxygenase-2-specific inhibitors. Am. J. Med. 2001, 110(3A):13S-19S.
11. Calvano S.E., Xiao W., Richards D.R., Felciano R.M., Baker H.V., Cho R.J., Chen R.O., Brownstein B.H., Cobb J.P., Tschoeke S.K., Miller-Graziano C., Moldawer L.L., Mindrinos M.N., Davis R.W., Tompkins R.G., Lowry S.F. A network-based analysis of systemic inflammation in humans. Nature 2005, 437:1032-1037.
12. Cho M.L., Jung Y.O., Moon Y.M., Min S.Y., Yoon C.H., Lee S.H., Park S.H., Cho C.S., Jue D.M., Kim H.Y. Interleukin-18 induces the production of vascular endothelial growth factor (VEGF) in rheumatoid arthritis synovial fibroblasts via AP-1-dependent pathways. Immunol. Lett. 2005, 103:159-166.
13. Commandeur J.N.M., Vermeulen N.P.E. Cytotoxicity and cytoprotective activities of natural compounds. The case of curcumin. Xenobiotica 1996, 26:667-680.
14. Creamer P., Hochberg M.C. Osteoarthritis. Lancet 1997, 350:503-508.
15. Csaki C., Mobasheri A., Shakibaei M. Synergistic chondroprotective effects of curcumin and resveratrol in human articular chondrocytes: inhibition of IL-1β-induced NF-κB-mediated inflammation and apoptosis. Arthritis Res. Ther. 2009, 11:R165.
16. Farinacci M., Gaspardo B., Colitti M., Stefanon B. Dietary administration of curcumin modifies transcriptional of genes involved in inflammatory cascade in horse leukocytes. Italian J. Anim. Sci. Atti del XVIII Congresso Nazionale A.S.P.A 2009, 84-86.
17. Farinacci M., Colitti M., Stefanon B. Modulation of ovine neutrophil function and apoptosis by standardized extracts of Echinacea angustifolia, Butea frondosa and Curcuma longa. Vet. Immunol. Immunopathol. 2009, 128:366-373.
18. Felson D.T., Zhang Y. An update on the epidemiology of knee and hip osteoarthritis with a view to prevention. Arthritis Rheum. 1998, 41:1343-1355.
19. Fernandes J.C., Martel-Pelletier J., Pelletier J.P. The role of cytokines in osteoarthritis pathophysiology. Biorheology 2002, 39:237-246.
20. Guha M., Mackman N. LPS induction of gene expression in human monocytes. Cell Signal. 2001, 13:5-94.
21. Henrotin Y., Kurz B. Antioxidant to treat osteoarthritis: dream or reality?. Curr. Drug Targets 2007, 8:347-357.
22. Henrotin Y., Sanchez C., Balligand M. Pharmaceutical and nutraceutical management of canine osteoarthritis: present and future perspectives. Vet. J. 2005, 170:113-123.
23. Hu Y., Liang H., Du Y., Zhu Y., Wang X. Curcumin inhibits transforming growth factor-beta activity via inhibition of Smad signaling in HK-2 cells. Am. J. Nephrol. 2010, 31:332-341.
24. Innes J.F. Diagnosis and treatment of osteoarthritis in dogs. In Practice 1995, 17:102-109.
25. Innes J.F., Fuller C.J., Grover E.R., Kelly A.L., Burn J.F. Randomised, double-blind, placebo controlled parallel group study of P54FP for the treatment of dogs with osteoarthritis. Vet. Rec. 2003, 152:457-460.
26. Innes J.F., Clayton J., Lascelles B.D. Review of the safety and efficacy of long-term NSAID use in the treatment of canine osteoarthritis. Vet. Rec. 2010, 166:226-230.
27. Kagan V.E., Tyurina Y.Y. Recycling and redox cycling of phenolic antioxidants. Ann. N. Y. Acad. Sci. 1998, 854:425-434.
28. Li C.J., Li R.W., Wang Y.H., Elsasser T.H. Pathway analysis identifies perturbation of genetic networks induced by butyrate in a bovine kidney epithelial cell line. Funct. Integr. Genomics 2007, 7:193-205.
29. -ΔΔCT method. Methods 2001, 25:402-408.
30. López-Armada M.J., Sánchez-Pernaute O., Largo R., Diez-Ortego I., Palacios I., Egido J., Herrero-Beaumont G. Modulation of cell recruitment by anti-inflammatory agents in antigen-induced arthritis. Ann. Rheum. Dis. 2002, 61:1027-1030.
31. Miller J.S.M., Angeles F.M., Reuter B.K., Bobrowski P., Sandoval M. Dietary antioxidants protect gut epithelial cells from oxidant-induced apoptosis. BMC Complement. Altern. Med. 2001, 1:11.
32. Okunieff P., Xu J., Hu D., Liu W., Zhang L., Morrow G., Pentland A., Ryan J.L., Ding I. Curcumin protects against radiation-induced acute and chronic cutaneous toxicity in mice and decreases mRNA expression of inflammatory and fibrogenic cytokines. Int. J. Radiat. Oncol. Biol. Phys. 2006, 65:890-898.
33. Rockett J.C., Burczynski M.E. Introduction to surrogate tissue analysis. Surrogate Tissue Analysis 2006, Taylor & Francis Group, pp. 3-11. M.E. Burczynski, J.C. Rockett (Eds.).
34. Rozen S., Skaletsky H.J. Primer3 on the WWW for general users and for biologist programmers. Bioinformatics Methods and Protocols: Methods in Molecular Biology 2000, Humana Press, pp. 365-386.
35. Ryckman C., Vandal K., Rouleau P., Talbot M., Tessier P.A. Proinflammatory activities of S100: proteins S100A8 S100A9, and S100A8/A9 induce neutrophil chemotaxis and adhesion. J. Immunol. 2003, 170:3233-3242.
36. Saeed A.I., Bhagabati N.K., Braisted J.C., Liang W., Sharov V., Howe E.A., Li J., Thiagarajan M., White J.A., Quackenbush J. TM4 microarray software suite. Method Enzymol. 2006, 411:134-193.
37. Schäfer B.W., Heizmann C.W. The S100 family of EF-hand calcium binding proteins: functions and pathology. Trends Biochem. Sci. 1996, 21:134-140.
38. Shakibaei M., John T., Schulze-Tanzil G., Lehmann I., Mobasheri A. Suppression of NF-κB activation by curcumin leads to inhibition of expression of cyclo-oxygenase-2 and matrix metalloproteinase-9 in human articular chondrocytes: implications for the treatment of osteoarthritis. Biochem. Farmacol. 2007, 73:1434-1445.
39. Singh S., Aggarwal B.B. Activation of transcription factor NF-κB is suppressed by curcumin (diferuloylmethane). J. Biol. Chem. 1995, 270:30235.
40. Sreejayan N., Rao M.N.A. Free radical scavenging by curcuminoids. Arzneimittel Forschung - Drug Research 1996, 46:169-171.
41. Sreejayan N., Rao M.N.A. Nitric oxide scavenging by curcuminoids. J. Pharm. Pharmacol. 1997, 49:105-107.
42. Stansby G., Fuller B., Jeremy J., Cheetham K., Rolles K. Endothelin release-a facet of reperfusion injury in clinical liver transplantation?. Transplantation 1993, 56:239-240.
43. Surh Y.J., Chun K.S., Cha H.H., Han S.S., Keum Y.S., Park K.K., Lee S.S. Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: down-regulation of COX-2 and iNOS through suppression of NF-κB activation. Mutat. Res. 2001, 480:243-268.
44. Takeda K., Kaisho T., Akira S. Toll-like receptors. Ann. Rev. Immunol. 2003, 21:335-376.
45. Triantafyllopoulou A., Franzke C.W., Seshan S.V., Perino G., Kalliolias G.D., Ramanujam M., van Rooijen N., Davidson A., Ivashkiv L.B. Proliferative lesions and metalloproteinase activity in murine lupus nephritis mediated by type I interferons and macrophages. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:3012-3017.
46. Vane J., Botting R. Mechanisms of action of anti-inflammatory drugs. Improved Non-Steroidal Anti-Inflammatory Drugs: COX-2 Enzyme Inhibitors 1996, Kluwer Academic, Dordrecht, pp. 1-27. J. Vane, J. Botting, R. Botting (Eds.).
47. Wognum S., Lagoa C.E., Nagatomi J., Sacks M.S., Vodovotz Y. An exploratory pathways analysis of temporal changes induced by spinal cord injury in the rat bladder wall: insights on remodeling and inflammation. PLoS One 2009, 4:e5852.
48. Youn H.S., Saitoh S.I., Miyake K., Hwang D.H. Inhibition of homodimerization of toll-like receptor 4 by curcumin. Biochem. Pharmacol. 2006, 72:62-69.